Boston Scientific Corporation is a major player in the medical device industry. With a focus on innovation, the company continues to develop advanced medical technologies for diverse applications in healthcare. As a publicly traded entity, its stock performance is influenced by its operational success and market conditions.
Currently, Boston Scientific Corporation displays a stable performance with room for improvement in some areas. Below are the fundamental scores that rate its financial health and market standing.
Category | Score | Visual |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 4 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 1 |
The historical rating provides insight into the changes in Boston Scientific's financial metrics over time. Here's a comparison of the recent and past evaluations.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-10-03 | 3 | 4 | 4 | 5 | 1 | 1 | 1 |
2025-10-05 | 3 | 4 | 4 | 5 | 1 | 1 | 1 |
Analysts provide insights into potential stock price movements. The following table shows their price predictions for Boston Scientific.
High | Low | Median | Consensus |
---|---|---|---|
136 | 118 | 128.5 | 127.63 |
Analyst sentiment reflects the market perspective and can guide investment decisions. Below is a breakdown of current recommendations.
Recommendation | Count | Visual |
---|---|---|
Strong Buy | 2 | |
Buy | 38 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Boston Scientific Corporation showcases a stable financial footing with some areas of potential growth. The mixed historical performance suggests cautious optimism, supported by mostly favorable analyst sentiments that advocate buying. Watchfulness regarding debt levels is recommended, given their impact on overall stability. The positive outlook rests heavily on its innovations and market adaptability.